EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies

Rodrigo de Oliveira Cavagna iD, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Murilo Bonatelli iD, Iara Santana, Eduardo Caetano Albino da Silva, Gustavo Ramos Teixeira iD, Beatriz Garbe Zaniolo, Josiane Mourão Dias iD, Flávio Augusto Ferreira da Silva, Carlos Eduardo Baston Silva iD, Marcela Gondim Borges Guimarães und 8 weitere

The Oncologist · 2024

DOI: 10.1093/oncolo/oyae129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Rodrigo de Oliveira Cavagna und 19 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lung cancer in never-smoker (LCINS) patients accounts for 20% of lung cancer cases, and its biology remains poorly understood, particularly in genetically admixed populations. We elucidated the molecular profile of driver genes in Brazilian LCINS.

Methods

The mutational and gene fusion status of 119 lung adenocarcinomas from self-reported never-smoker patients, was assessed using targeted sequencing (NGS), nCounter, and immunohistochemistry. A panel of 46 ancestry-informative markers determined patients’ genetic ancestry.

Results

The most frequently mutated gene was EGFR (49.6%), followed by TP53 (39.5%), ALK (12.6%), ERBB2 (7.6%), KRAS (5.9%), PIK3CA (1.7%), and less than 1% alterations in RET, NTRK1, MET∆ex14, PDGFRA, and BRAF. Except for TP53 and PIK3CA, all other alterations were mutually exclusive. Genetic ancestry analysis revealed a predominance of European (71.1%), and a higher African ancestry was associated with TP53 mutations.

Conclusion

Brazilian LCINS exhibited a similar molecular profile to other populations, except the increased ALK and TP53 alterations. Importantly, 73% of these patients have actionable alterations that are suitable for targeted treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsMutationHumansMaleFemaleBrazilMiddle AgedAgedAdultMolecular Targeted TherapyAged, 80 and overBiomarkers, Tumor

Stichwörter der Autor:innen

Latin Americadriver mutationslung adenocarcinomamolecular profilenever smoker

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
  • Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.
  • Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, Barretos, Brazil.
  • Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil.
  • Deparment of Radiation Therapy, Barretos Cancer Hospital, Barretos, Brazil.

ORCID-Profile: Rodrigo de Oliveira Cavagna, Murilo Bonatelli, Gustavo Ramos Teixeira, Josiane Mourão Dias, Carlos Eduardo Baston Silva, Alexandre Arthur Jacinto, Pedro De Marchi, Miguel A Molina-Vila, Letícia Ferro Leal, Rui Manuel Reis

Zitieren

APA

Cavagna, R. O., Escremim de Paula, F., Berardinelli, G. N., Bonatelli, M., Santana, I., Albino da Silva, E. C., Teixeira, G. R., Zaniolo, B. G., Mourão Dias, J., Ferreira da Silva, F. A., Baston Silva, C. E., Guimarães, M. G. B., Barone, C. P., Jacinto, A. A., Noleto da Nóbrega Oliveira, R. E., Miziara, J. E., De Marchi, P., Molina-Vila, M. A., Leal, L. F., & Reis, R. M. (2024). Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies. The Oncologist. https://doi.org/10.1093/oncolo/oyae129

Vancouver

Cavagna RO, Escremim de Paula F, Berardinelli GN, Bonatelli M, Santana I, Albino da Silva EC, et al. Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies. The Oncologist. 2024. doi:10.1093/oncolo/oyae129

BibTeX
@article{Cavagna2024,
  author = {Cavagna, Rodrigo de Oliveira and Escremim de Paula, Flávia and Berardinelli, Gustavo Noriz and Bonatelli, Murilo and Santana, Iara and Albino da Silva, Eduardo Caetano and Teixeira, Gustavo Ramos and Zaniolo, Beatriz Garbe and Mourão Dias, Josiane and Ferreira da Silva, Flávio Augusto and Baston Silva, Carlos Eduardo and Guimarães, Marcela Gondim Borges and Barone, Camila Pinto and Jacinto, Alexandre Arthur and Noleto da Nóbrega Oliveira, Rachid Eduardo and Miziara, José Elias and De Marchi, Pedro and Molina-Vila, Miguel A and Leal, Letícia Ferro and Reis, Rui Manuel},
  title = {Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies},
  journal = {The Oncologist},
  year = {2024},
  doi = {10.1093/oncolo/oyae129}
}
Kostenlos starten →